A new diagnostic system that combines optical coherence tomography (OCT) and fractional flow reserve (FFR) technologies on a single platform has gained CE Mark approval for sale in the EU.
The Ilumien system from St. Jude Medical integrates physiological and anatomical information to improve the diagnosis and treatment of coronary artery disease.
The new system combines the PressureWire Aeris, a wireless device that measures FFR to assess the severity of blockages in the coronary arteries, with the C7-XR OCT diagnostic imaging technology. The latter’s unique intravascular imaging technology, Extreme Resolution, enables precise measurement of lesion dimensions and vessel size and structure.
Together, the two technologies enable the optimisation of percutaneous coronary intervention (PCI).
Additionally, the Ilumien system features the Wi-Box, a wireless device that receives aortic pressure readings from the catheterisation lab.
“The Ilumien system provides me and my colleagues with an easy-to-use, flexible solution that combines OCT and FFR technology,” said Dr. Evelyn Regar, Associate Professor, Department of Interventional Cardiology Thoraxcenter in Rotterdam, Netherlands. “Having these two cutting-edge technologies together is a welcome advancement for therapy guidance, allowing me to choose the right tools for each patient situation.”
“Knowing which lesion to treat and how to treat it is the key to optimizing interventional treatment strategies,” said Frank J. Callaghan, President of the St. Jude Medical Cardiovascular Division. “We believe integrating these technologies is key to providing physicians a simplified, streamlined option for the diagnosis and treatment of patients with coronary artery disease.”
St. Jude Medical is based in Minnesota, USA.